George Clinical Helps Biotech Deliver Cell and Gene Therapy Study with Best-in-Class Data
Early risk identification and comprehensive quality management plan ensured best possible outcome.
Read MoreEarly risk identification and comprehensive quality management plan ensured best possible outcome.
Read MoreCollaborative teamwork results in success for this study involving rare indication in a pediatric / young adult population.
Read MoreEarly phase oncology expertise and established local relationships make George Clinical the CRO of choice for Chinese biotech.
Read MoreFirst patient screening in seven months avoided lapse in Chinese regulatory approval.
Read MoreChallenges included specialized equipment, interaction with multiple departments and stringent COVID restrictions.
Read MoreDespite operational delays, COVID interruptions and Ukraine war outbreak, targets were met.
Read MoreLocal knowledge combined with Australia’s favorable conditions keep trial on track and on time. Early phase clinical trials are the first-line research studies in drug development and assess therapies for safety, dosage levels and side effects. These studies form the basis for all further research on therapy, so they must be conducted to very high […]
Read MoreWe work to keep every patient engaged to the end from risk retention and personal contact with clinical research associates (CRAs) to patient-facing animation in 20 languages. Clinical trials for rare diseases pose specific challenges due to their elusive nature and low patient populations. Research is critical for these often serious and even life-threatening diseases […]
Read MoreExceptional kidney and metabolic scientific leadership network provides continuity, communication and cultural expertise in long-term global trial program. Background The National Institute of Diabetes and Digestive and Kidney Diseases (NIH) estimates that more than one in seven people with kidney disease have anemia, increasing their chance of developing heart problems and strokes. The prevalence […]
Read MoreAbility to work across cultural, language and timeline barriers sets benchmark and achieves record patient recruitment in China despite pandemic. Situation A Canadian CRO conducting a global and important Phase III early breast cancer trial for a major pharmaceutical company engaged George Clinical as its partner for the Chinese portion of the trial. Globally, the […]
Read More